Antipsychotic Agents: all 1,683 studies that test it

Page 9 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.

• Simplified Algorithm for the Prevention of Postoperative Nausea and Vomiting in an Oncological HospitalCompletedNCT04411069Phase 2
• A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I DepressionTerminatedNCT04383691Phase 3
• Cariprazine Pediatric ASD PK StudyCompletedNCT04382885Phase 1
• Repurposing of Chlorpromazine in Covid-19 TreatmentWithdrawnNCT04366739Phase 3
• Administration of Chlorpromazine as a Treatment for COVID-19Status unknownNCT04354805Phase 2/3
• Amisulpride Treatment for BPSD in AD PatientsStatus unknownNCT04341467Not applicable
• Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain InjuryCompletedNCT04280965Early Phase 1
• Olanzapine for Chemotherapy-induced Nausea and Vomiting ProphylaxisCompletedNCT04232423Phase 3
• Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental DisordersCompletedNCT04218981Not applicable
• A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical FeaturesStatus unknownNCT04209166Not applicable
• Treatment Strategies in CHSCompletedNCT04176055Phase 4
• A Study of Staccato Loxapine (ADASUVE®) for InhalationStatus unknownNCT04148963Phase 3
• Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or SchizophreniaCompletedNCT04127058Phase 1
• Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapyCompletedNCT04075955Phase 3
• Symptomatic Therapy for Patients With Huntington's DiseaseStatus unknownNCT04071639Phase 1
• The Sub-Sero StudyWithdrawnNCT03994965Phase 2
• Rolapitant Plus Olanzapine in Multiday Cisplatin ChemotherapyWithdrawnNCT03960151Phase 2
• Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.CompletedNCT03947216Phase 2
• Gender Influence on Torsadogenic Actions of Droperidol.CompletedNCT03944681Not applicable
• Therapeutic Issues for AutismCompletedNCT03887754Phase 2
• Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-upStatus unknownNCT03883204Phase 4
• DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using AripiprazoleStatus unknownNCT03881449Phase 4
• Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic ChemotherapyStatus unknownNCT03876938Phase 3
• Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar DisorderCompletedNCT03872596Phase 1
• Influence of Dopaminergic Blockade on Stress Responses, Motivation and Emotional Reactivity in Humans.CompletedNCT03863691Not applicable
• Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use DisorderStatus unknownNCT03857581Phase 4
• A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I DisorderCompletedNCT03854409Phase 1
• Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia PatientsCompletedNCT03839251Phase 4
• Reducing the Abuse of Opioids in Drug UsersTerminatedNCT03837860Early Phase 1
• Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia IndividualsStatus unknownNCT03790085Early Phase 1
• Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For SchizophreniaActive, not recruitingNCT03781115Phase 1
• Pharmacological Modulation of Belief SalienceCompletedNCT03754062Phase 1
• Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative CareActive, not recruitingNCT03743649Phase 2/3
• Intranasal Insulin and Olanzapine Study in Healthy VolunteersCompletedNCT03741478Phase 1
• Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical AntipsychoticsCompletedNCT03730857Phase 1
• A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare FacilitiesCompletedNCT03713658Phase 4
• Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer CareStatus unknownNCT03679182Phase 2
• Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination TherapyCompletedNCT03652974Phase 4
• Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic PatientsCompletedNCT03631004Phase 2/3
• Haloperidol for Delirium in Adult Critically Ill PatientsTerminatedNCT03628391Phase 3
• Study of APD421 With and Without OndansetronCompletedNCT03583489Phase 1
• Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric CancerStatus unknownNCT03575637Phase 2
• Quetiapine Treatment for Pediatric DeliriumWithdrawnNCT03572257Phase 2/3
• Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung CancerStatus unknownNCT03571126Phase 4
• Comparative Bioavailability of RisperidoneCompletedNCT03527186Phase 1
• Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)CompletedNCT03510325Phase 3
• Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's SyndromeCompletedNCT03487783Phase 3
• Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic DisorderCompletedNCT03487770Phase 3
• Substance Misuse To Psychosis for StimulantsCompletedNCT03485417Phase 2/3
• Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) ProphylaxisStatus unknownNCT03478605Phase 2
• Bioequivalence Study to Compare Two Formulations of Deanxit®CompletedNCT03472651Phase 1
• A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With SchizophreniaCompletedNCT03465787Phase 3
• Cariprazine Effects on Brain and Behavior in Cocaine Use DisorderTerminatedNCT03430544Phase 2
• A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This TreatmentCompletedNCT03425552Phase 1/2
• Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone TabletsStatus unknownNCT03420534Phase 1
• A Study of Lurasidone HCl in Subjects With SchizophreniaCompletedNCT03393026Phase 4
• Agents Intervening Against Delirium in Intensive Care UnitStatus unknownNCT03392376Phase 4
• MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical AntipsychoticsCompletedNCT03376763Phase 4
• Exploring the Role of the GABAergic Modulation in Pain Transmission in HumanCompletedNCT03375034Phase 1
• Bioequivalence Study of Two Extended Release Formulations Containing 50 mg of Quetiapine.CompletedNCT03317236Phase 4
• Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated SchizophreniaCompletedNCT03304457Phase 4
• Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World StudyCompletedNCT03289026Phase 4
• Aripiprazole IM Depot for Chinese Patients With SchizophreniaCompletedNCT03287505Phase 1
• PK Study of Aripiprazole IM Depot for Chinese Patients With SchizophreniaCompletedNCT03285503Phase 1
• A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT03272503Phase 2
• Oral Olanzapine Versus Haloperidol or DiazepamTerminatedNCT03246620Phase 4
• Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed ConditionStatus unknownNCT03232710Not applicable
• Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?TerminatedNCT03227562Phase 3
• Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy ParticipantsWithdrawnNCT03220867Phase 1
• "Olanzapine for Prevention of Chemotherapy Induced Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy (HEC)"CompletedNCT03219710Phase 3
• Treatment in Patients With Globus: Psychoeducation, Anxiolytics or Proton Pump InhibitorsCompletedNCT03205228Phase 3
• PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdelStatus unknownNCT03199950Phase 4
• The Effect of Chlorpromazine on Esophageal Sensitivity in Healthy Volunteers.Status unknownNCT03183310Not applicable
• Aripiprazole IM Depot in the Acute Treatment of Adults With SchizophreniaCompletedNCT03172871Phase 3
• Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With SchizophreniaCompletedNCT03150771Phase 1
• A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward PathwayStatus unknownNCT03148509Phase 4
• RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic ChemotherapyCompletedNCT03118986Phase 2
• Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-upStatus unknownNCT03090503Phase 4
• The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With SchizophreniaStatus unknownNCT03080194Phase 4
• Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer PatientsCompletedNCT03079219Phase 3
• Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With SchizophreniaCompletedNCT03075657Phase 4
• Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)CompletedNCT03056482Phase 4
• Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia RepairCompletedNCT03023462Not applicable
• Gene-by-Stress Interactions in Intervention Studies SignificanceTerminatedNCT03011645Phase 1
• Lithium Versus Quetiapine in Treatment Resistant DepressionStatus unknownNCT03004521Phase 4
• Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CINStatus unknownNCT02970643Not applicable
• Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic ProfileCompletedNCT02949752Phase 4
• The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic AgitationStatus unknownNCT02935998Phase 4
• The Optimal Treatment for Treatment-resistant SchizophreniaStatus unknownNCT02926976Not applicable
• An Insulin Sensitivity Study in Healthy SubjectsCompletedNCT02922426Phase 1
• Long-acting Paliperidone Palmitate Injection and Olanzapine for SchizophreniaCompletedNCT02918825Not applicable
• Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural SedationCompletedNCT02909465Phase 4
• Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).Status unknownNCT02909088Phase 2/3
• Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective DisorderCompletedNCT02901587Phase 1
• [18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in PsychosisStatus unknownNCT02880995Not applicable
• Intra-operative Injection of Autologous Conditioned Plasma (ACP) Following Partial MeniscectomyCompletedNCT02872753Phase 4
• Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD StudyCompletedNCT02861859Phase 3
• Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic PainTerminatedNCT02820519Phase 2
• A Phase 1 Safety Study in Adults With SchizophreniaCompletedNCT02804568Phase 1
• Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCTStatus unknownNCT02779959Phase 3

← Antipsychotic Agents overview